Copyright
©The Author(s) 2019.
World J Hepatol. Dec 27, 2019; 11(12): 752-760
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Table 3 Predisposing factors, n (%)
Predisposing factors | GCH on native liver | GCH on allograft |
AIH | 13 (32) | 3 (30) |
Drug induced | 6 (15) | 0 |
No factor identified | 12 (30) | 3 (30) |
UC | 2 (5) | 3 (30) |
PSC | 3 (7) | 1 (10) |
HCV | 2 (5) | 1 (10) |
CMV | 1 (2) | 1 (10) |
SLE | 2 (5) | 0 |
Lymphoma | 2 (5) | 0 |
HAV | 1 (2) | 0 |
HBV | 1 (2) | 0 |
EBV | 1 (2) | 0 |
Sjogren | 1 (2) | 0 |
Autoimmune hemolytic anemia | 1 (2) | 0 |
CLL | 1 (2) | 0 |
Peripheral eosinophilia | 1 (2) | 0 |
SCC | 1 (2) | 0 |
Celiac disease | 1 (2) | 0 |
- Citation: Matta B, Cabello R, Rabinovitz M, Minervini M, Malik S. Post-infantile giant cell hepatitis: A single center’s experience over 25 years. World J Hepatol 2019; 11(12): 752-760
- URL: https://www.wjgnet.com/1948-5182/full/v11/i12/752.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i12.752